Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
2,046
Value
$36.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SRPT by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,046$36.8K<0.1%−491−19.4%ReducedHolders
Q1 20262,537$55.2K<0.1%+435+20.7%AddedHolders
Q4 20252,102$45.2K<0.1%+86+4.3%AddedHolders
Q3 20252,016$38.8K<0.1%+1,256+165.3%AddedHolders
Q2 2025760$13.0K<0.1%−233−23.5%ReducedHolders
Q1 2025993$63.6K<0.1%+170+20.7%AddedHolders
Q4 2024823$100.1K<0.1%−3−0.4%ReducedHolders
Q3 2024826$103.2K<0.1%+140+20.4%AddedHolders
Q2 2024686$108.4K<0.1%+61+9.8%AddedHolders
Q1 2024625$80.9K<0.1%+17+2.8%AddedHolders
Q4 2023608$58.6K<0.1%−15−2.4%ReducedHolders
Q3 2023623$75.5K<0.1%−21−3.3%ReducedHolders
Q2 2023644$73.8K<0.1%+478+288.0%AddedHolders
Q1 2023166$22.9K<0.1%+5+3.1%AddedHolders
Q4 2022161$20.9K<0.1%−280−63.5%ReducedHolders
Q3 2022441$49.0K<0.1%+84+23.5%AddedHolders
Q2 2022357$27.0K<0.1%−18−4.8%ReducedHolders
Q1 2022375$29.0K<0.1%−106−22.0%ReducedHolders
Q4 2021481$43.0K<0.1%+100+26.2%AddedHolders
Q3 2021381$35.0K<0.1%+162+74.0%AddedHolders
Q2 2021219$17.0K<0.1%+39+21.7%AddedHolders
Q1 2021180$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.